𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Benefit or risk of aspirin treatment of giant cell arteritis: Comment on the article by Weyand et al

✍ Scribed by Bruce M. Rothschild


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
114 KB
Volume
46
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Giant cell arteritis disease patterns: C
✍ Alan B. Marks πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 111 KB πŸ‘ 2 views

al report that filtration leukocytapheresis represents an advance in the management of rheumatoid arthritis (1). I do not believe this procedure is as advantageous as centrifugal online lymphoplasmapheresis for the following reasons: 1. Filtration leukocytapheresis removed only 1.9 Ο« 10 9 lymphocyt

Glucocorticoid therapy in giant cell art
✍ Docken, William P. πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 47 KB πŸ‘ 1 views

The recent article by PrΓΈven et al (PrΓΈven A, Gabriel S, Orces C, O'Fallon WM, Hunder GG. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 2003;49:703-8) emphasizes the toxicities inherent in the use of high-dose steroids for the management of giant cell

Benefit of high-dose intravenous methylp
✍ Kayvan Arashvand πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 33 KB πŸ‘ 2 views

consequences of a variety of compounds that are used may be quite significant (1-5). As noted by Pollard and Hultman, these products are available and used worldwide, but the extent to which they are currently used, or have previously been used, by different groups (in the US and in other countries)